Quick Answer
PALISADE BIO, INC. reported Total Assets of $134.34 million for the year ending 2025.
- PALISADE BIO, INC. showed an increase of +1,134.8% in Total Assets from 2024 to 2025.
- This data is from PALISADE BIO, INC.'s annual report (Form 10-K), filed with the SEC on March 20, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $7.42 million | Q3 2011: $5.89 million | Q1 2012: $6.85 million | Q2 2012: $3.96 million | Q3 2012: $11.24 million | Q1 2013: $15.41 million | Q2 2013: $13.80 million | Q3 2013: $19.17 million | Q1 2014: $35.92 million | Q2 2014: $32.63 million | Q3 2014: $29.44 million | Q1 2015: $30.80 million | Q2 2015: $26.37 million | Q3 2015: $21.14 million | Q1 2016: $10.20 million | Q2 2016: $13.29 million | Q3 2016: $8.45 million | Q1 2017: $18.73 million | Q2 2017: $13.27 million | Q3 2017: $16.19 million | Q1 2018: $11.55 million | Q2 2018: $9.23 million | Q3 2018: $7.72 million | Q1 2019: $5.41 million | Q2 2019: $3.52 million | Q3 2019: $8.94 million | Q1 2020: $11.36 million | Q2 2020: $17.10 million | Q3 2020: $15.17 million | Q1 2021: $8.91 million | Q2 2021: $14.95 million | Q3 2021: $16.27 million | Q1 2022: $8.35 million | Q2 2022: $7.81 million | Q3 2022: $16.27 million | Q1 2023: $15.26 million | Q2 2023: $18.29 million | Q3 2023: $17.07 million | Q1 2024: $12.65 million | Q2 2024: $12.87 million | Q3 2024: $9.34 million | Q1 2025: $8.19 million | Q2 2025: $6.67 million | Q3 2025: $6.97 million.
- Over the full 16 years of available data (2010 to 2025), PALISADE BIO, INC.'s Total Assets has grown by 1,168.4%.
- Historical annual values: Fiscal year 2025: $134.34 million | Fiscal year 2024: $10.88 million | Fiscal year 2023: $14.05 million | Fiscal year 2022: $15.76 million | Fiscal year 2021: $12.51 million | Fiscal year 2020: $3.02 million | Fiscal year 2019: $6.58 million | Fiscal year 2018: $7.68 million | Fiscal year 2017: $13.88 million | Fiscal year 2016: $22.60 million | Fiscal year 2015: $14.95 million | Fiscal year 2014: $29.84 million | Fiscal year 2013: $19.41 million | Fiscal year 2012: $8.75 million | Fiscal year 2011: $4.09 million | Fiscal year 2010: $10.59 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: